Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04790474
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-21
First Post:
2021-03-07
Brief Title:
Ixazomib-pomalidomide-dexamethasone As Second or Third-line Combination Treatment for Patients with Relapsed and Refractory Multiple Myeloma Previously Treated with Daratumumab Lenalidomide and Bortezomib
Sponsor:
Organization:
Tel-Aviv Sourasky Medical Center